1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cardiomyopathy, Dilated in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ichihara, S; McKenna, CJ; Yamada, Y; Yokota, M | 1 |
Gabbasov, ZA; Naumov, VG; Okur, FM; Popov, EG; Skvortsov, AA | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cardiomyopathy, Dilated
Article | Year |
---|---|
Familial dilated cardiomyopathy.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Cardiomyopathy, Dilated; Humans; Mutation, Missense; Phospholipases A; Platelet Activating Factor | 1999 |
[New approaches to the study of thrombocyte aggregation in patients with dilated cardiomyopathy].
Topics: Adenosine Diphosphate; Adolescent; Adult; Cardiomyopathy, Dilated; Culture Media; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Platelet Function Tests; Stimulation, Chemical | 1989 |